RxDoctor Payments Data

Lawrence Gratkins, MD

Obstetrics & Gynecology · Normal, ILNPI 1912003013

Payments from drug & device makers

$4,770in general payments, 2019–2025

Across 262 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$400
  • Astellas Pharma US Inc$354
  • Exeltis, USA Inc.$292
  • Therapeuticsmd, Inc.$272
  • Biogen$248
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$4,64597%
  • Education$1243%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,770 in reported general payments places this provider in the 90th percentile of 1,732 obstetrics & gynecology providers in Illinois.

See all obstetrics & gynecology providers in Illinois

Medicare billing

Part B allowed, 2024
$14,341
Medicare patients
64
Services billed
141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanumetSitagliptin Phos/Metformin Hcl19$11,057
PremarinEstrogens, Conjugated21$6,513
SynthroidLevothyroxine Sodium26$2,688
Estradiol36$961
Propranolol Hcl ErPropranolol Hcl13$820
Levothyroxine Sodium53$672
Estradiol (Twice Weekly)Estradiol12$623
Raloxifene Hcl12$454
Sertraline Hcl11$119
Alprazolam15$117
Megestrol Acetate12$102
Hydrochlorothiazide11$80
Ibuprofen13$35

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanumet$51$11,05719 claims
PfizerPremarin$400$6,51321 claims
AbbVieSynthroid$1,439$2,68826 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$59$67253 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,732 obstetrics & gynecology providers in Illinois.

Other obstetrics & gynecology in Normal

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →